IDH2 and neoplasm: A significant accumulation of 2-HG into cells was described in AML patients with IDH mutations [23], causing the inhibition of α-KG-dependent enzymes [24] and the consequent deregulation of the methylation state of DNA and gene expression, which can activate oncogenes and inactivate tumor-suppressor genes.